Minta, M.;                     Kurzawińska, G.;                     Banach Minta, Z.;                     Seremak Mrozikiewicz, A.;                     Szpecht, D.    
        Prostaglandin Pathway Polymorphisms and HsPDA Treatment Outcomes in Preterm Infants below 32 Weeks: Pilot Study. Genes 2025, 16, 1271.
    https://doi.org/10.3390/genes16111271
    AMA Style
    
                                Minta M,                                 Kurzawińska G,                                 Banach Minta Z,                                 Seremak Mrozikiewicz A,                                 Szpecht D.        
                Prostaglandin Pathway Polymorphisms and HsPDA Treatment Outcomes in Preterm Infants below 32 Weeks: Pilot Study. Genes. 2025; 16(11):1271.
        https://doi.org/10.3390/genes16111271
    
    Chicago/Turabian Style
    
                                Minta, Marcin,                                 Grażyna Kurzawińska,                                 Zuzanna Banach Minta,                                 Agnieszka Seremak Mrozikiewicz,                                 and Dawid Szpecht.        
                2025. "Prostaglandin Pathway Polymorphisms and HsPDA Treatment Outcomes in Preterm Infants below 32 Weeks: Pilot Study" Genes 16, no. 11: 1271.
        https://doi.org/10.3390/genes16111271
    
    APA Style
    
                                Minta, M.,                                 Kurzawińska, G.,                                 Banach Minta, Z.,                                 Seremak Mrozikiewicz, A.,                                 & Szpecht, D.        
        
        (2025). Prostaglandin Pathway Polymorphisms and HsPDA Treatment Outcomes in Preterm Infants below 32 Weeks: Pilot Study. Genes, 16(11), 1271.
        https://doi.org/10.3390/genes16111271